Skip to main content
Livermore
Livermore
ZHEN

Commerce Bank

SEC CIK
0001009076
Latest filing
Aug 12, 2026

HALO holding history

Halozyme Therapeutics, Inc. in every 13F filed by Commerce Bank, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HALO overviewAll 13F holders of HALOFull Q2 2026 holdings

Shares (Q2 2026)
17,206
Value
$1.35M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of HALO by Commerce Bank, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202617,206$1.35M<0.1%−654−3.7%ReducedHolders
Q1 202617,860$1.15M<0.1%−82−0.5%ReducedHolders
Q4 202517,942$1.21M<0.1%+9,298+107.6%AddedHolders
Q3 20258,644$634.0K<0.1%−463−5.1%ReducedHolders
Q2 20259,107$473.7K<0.1%−55−0.6%ReducedHolders
Q1 20259,162$584.6K<0.1%−1,449−13.7%ReducedHolders
Q4 202410,611$507.3K<0.1%−90−0.8%ReducedHolders
Q3 202410,701$612.5K<0.1%−3,920−26.8%ReducedHolders
Q2 202414,621$765.6K<0.1%00.0%UnchangedHolders
Q1 202414,621$594.8K<0.1%−39−0.3%ReducedHolders
Q4 202314,660$541.8K<0.1%−481−3.2%ReducedHolders
Q3 202315,141$578.4K<0.1%−195−1.3%ReducedHolders
Q2 202315,336$553.2K<0.1%−159−1.0%ReducedHolders
Q1 202315,495$591.8K<0.1%−382−2.4%ReducedHolders
Q4 202215,877$903.4K<0.1%−3,785−19.3%ReducedHolders
Q3 202219,662$777.0K<0.1%+711+3.8%AddedHolders
Q2 202218,951$834.0K<0.1%+113+0.6%AddedHolders
Q1 202218,838$751.0K<0.1%−159−0.8%ReducedHolders
Q4 202118,997$763.0K<0.1%+3,296+21.0%AddedHolders
Q3 202115,701$639.0K<0.1%+2,191+16.2%AddedHolders
Q2 202113,510$614.0K<0.1%+22+0.2%AddedHolders
Q1 202113,488$562.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.